World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
67
Citations
21962
World Ranking
8081
National Ranking
620

Overview

Timothy D. McHugh is affiliated with University College London in the United Kingdom. Their research primarily focuses on medicine, with a significant emphasis on infectious diseases. The main fields of study include:

  • Medicine

The subfields of study span:

  • Infectious Diseases
  • Epidemiology
  • Molecular Medicine
  • Surgery
  • Molecular Biology

The central topics in their research involve:

  • Tuberculosis Research and Epidemiology
  • Mycobacterium research and diagnosis
  • Antibiotic Resistance in Bacteria
  • Pneumonia and Respiratory Infections
  • SARS-CoV-2 and COVID-19 Research
  • Infectious Diseases and Tuberculosis
  • Pneumocystis jirovecii pneumonia detection and treatment

Frequently publishing in several scientific journals, McHugh has contributed to:

  • Annals of Clinical Microbiology and Antimicrobials
  • bioRxiv (Cold Spring Harbor Laboratory)
  • International Journal of Infectious Diseases
  • Journal of Antimicrobial Chemotherapy
  • The Lancet Infectious Diseases

Among the noted recent papers connected to their work are:

  • The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China (2020), International Journal of Infectious Diseases
  • Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts (2021), International Journal of Infectious Diseases
  • Treatment of Highly Drug-Resistant Pulmonary Tuberculosis (2020), New England Journal of Medicine
  • Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis (2022), New England Journal of Medicine
  • A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis (2022), New England Journal of Medicine

Collaborations have often involved the following co-authors:

  • Linzy Elton
  • Alimuddin Zumla
  • Francine Ntoumi
  • Norbert Heinrich
  • Michael Höelscher

Best Publications

  • The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China.

    David S. Hui;Esam Ei Azhar;Tariq A. Madani;Francine Ntoumi

  • Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts.

    Jeremiah Chakaya;Jeremiah Chakaya;Mishal Khan;Francine Ntoumi;Eleni Aklillu

  • Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis

    Stephen H. Gillespie;Angela M. Crook;Timothy D. McHugh;Carl M. Mendel

  • Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

    Francesca Conradie;Andreas H. Diacon;Nosipho Ngubane;Pauline Howell

  • Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test

    Stephen D Lawn;Peter Mwaba;Peter Mwaba;Matthew Bates;Amy Piatek

  • High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis

    Amina Jindani;Thomas S. Harrison;Andrew J. Nunn;Patrick P.J. Phillips

  • New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects

    Alimuddin I Zumla;Alimuddin I Zumla;Stephen H Gillespie;Michael Hoelscher;Patrick P J Philips

  • Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies

    Simon Tiberi;Nelita du Plessis;Gerhard Walzl;Michael J Vjecha

  • Drug-resistant tuberculosis: time for visionary political leadership

    Ibrahim Abubakar;Ibrahim Abubakar;Matteo Zignol;Dennis Falzon;Mario Raviglione

  • A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis

    M.J. Boeree;A.H. Diacon;R. Dawson;K. Narunsky

  • Tuberculosis: advances and challenges in development of new diagnostics and biomarkers

    Gerhard Walzl;Gerhard Walzl;Ruth McNerney;Nelita du Plessis;Nelita du Plessis;Matthew Bates;Matthew Bates

  • Physiological Cost of Rifampin Resistance Induced In Vitro in Mycobacterium tuberculosis

    O. J. Billington;T. D. McHugh;S. H. Gillespie

  • Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical Samples

    Amanda C. Brown;Josephine M. Bryant;Katja Einer-Jensen;Jolyon Holdstock

  • Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD

    Davinder S Garcha;Sarah J Thurston;Anant R C Patel;Alexander J Mackay

  • Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities

    Ruth McNerney;Markus Maeurer;Ibrahim Abubakar;Ibrahim Abubakar;Ben Marais

  • RE: “ESTIMATED RATE OF REACTIVATION OF LATENT TUBERCULOSIS INFECTION IN THE UNITED STATES, OVERALL AND BY POPULATION SUBGROUP”

    R. M. G. J. Houben;T. A. Yates;D. A. J. Moore;T. D. McHugh

  • Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study

    Josephine M Bryant;Simon R Harris;Julian Parkhill;Rodney Dawson

  • The transmission of Mycobacterium tuberculosis in high burden settings

    Tom A Yates;Tom A Yates;Palwasha Y Khan;Gwenan M Knight;Gwenan M Knight;Jonathon G Taylor

  • Drug-Resistant Tuberculosis—Current Dilemmas, Unanswered Questions, Challenges, and Priority Needs

    Alimuddin Zumla;Ibrahim Abubakar;Mario Raviglione;Michael Hoelscher

  • Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future

    Nathan Kapata;Chikwe Ihekweazu;Francine Ntoumi;Francine Ntoumi;Tajudeen Raji

Frequent Co-Authors

Stephen H. Gillespie
Stephen H. Gillespie University of St Andrews
Marc Lipman
Marc Lipman Royal Free London NHS Foundation Trust
Ibrahim Abubakar
Ibrahim Abubakar University College London
Alimuddin Zumla
Alimuddin Zumla University College London
Andrew Nunn
Andrew Nunn University College London
Michael Hoelscher
Michael Hoelscher Ludwig-Maximilians-Universität München
Jadwiga A. Wedzicha
Jadwiga A. Wedzicha Imperial College London
Markus Maeurer
Markus Maeurer Champalimaud Foundation
Giuseppe Ippolito
Giuseppe Ippolito Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
Philip D. Butcher
Philip D. Butcher St George's, University of London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As interest in Biology and Biochemistry grows, students have more flexible options than ever to advance their education online. One fast-track solution for working professionals or those eager to enter the workforce is the accelerated biology degree, which allows learners to complete coursework at a quicker pace while maintaining academic rigor.

For those drawn to healthcare, programs such as online ASN programs provide vital skills and qualifications for registered nursing roles, offering convenience without sacrificing instructional quality. Alternatively, students interested in health and wellness might consider an online degree in nutrition, opening doors to careers in dietetics, public health, and food research.

Professionals aiming for leadership roles in healthcare may also look into the number of cahme accredited mha programs available online, ensuring high standards and recognized credentials. Each of these online pathways offers tailored career opportunities, showcasing the diversity and adaptability of biological and health sciences in today's digital education landscape.

Best Scientists Citing Timothy D. McHugh

Trending Scientists